1	Attenuated	attenuate	VBN	VBN	_	4	amod	_	_
2	Bordetella	bordetella	NN	NN	_	4	nn	_	_
3	pertussis	pertussis	NN	NN	_	4	nn	_	_
4	vaccine	vaccine	NN	NN	_	5	nsubj	_	_
5	protects	protect	VBZ	VBZ	_	0	ROOT	_	_
6	against	against	IN	IN	_	5	prep	_	_
7	respiratory	respiratory	JJ	JJ	_	10	amod	_	_
8	syncytial	syncytial	JJ	JJ	_	10	amod	_	_
9	virus	virus	NN	NN	_	10	nn	_	_
10	disease	disease	NN	NN	_	6	pobj	_	_
11	via	via	IN	IN	_	5	prep	_	_
12	an	a	DT	DT	_	14	det	_	_
13	IL-17-dependent	il-17-dependent	JJ	JJ	_	14	amod	_	_
14	mechanism	mechanism	NN	NN	_	11	pobj	_	_
15	.	.	.	.	_	5	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	attenuated	attenuate	VBD	VBD	_	0	ROOT	_	_
3	virulent	virulent	JJ	JJ	_	5	amod	_	_
4	Bordetella	bordetella	NN	NN	_	5	nn	_	_
5	pertussis	pertussis	NN	NN	_	2	dobj	_	_
6	by	by	IN	IN	_	2	prep	_	_
7	genetically	genetically	RB	RB	_	8	advmod	_	_
8	eliminating	eliminate	VBG	VBG	_	6	pcomp	_	_
9	or	or	CC	CC	_	8	cc	_	_
10	detoxifying	detoxify	VBG	VBG	_	8	conj	_	_
11	three	three	CD	CD	_	13	num	_	_
12	major	major	JJ	JJ	_	13	amod	_	_
13	toxins	toxin	NNS	NNS	_	8	dobj	_	_
14	.	.	.	.	_	2	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	strain	strain	NN	NN	_	9	nsubjpass	_	_
3	,	,	,	,	_	2	punct	_	_
4	named	name	VBN	VBN	_	2	vmod	_	_
5	BPZE1	bpze1	NN	NN	_	4	dep	_	_
6	,	,	,	,	_	2	punct	_	_
7	is	be	VBZ	VBZ	_	9	aux	_	_
8	being	be	VBG	VBG	_	9	auxpass	_	_
9	developed	develop	VBN	VBN	_	0	ROOT	_	_
10	as	as	IN	IN	_	9	prep	_	_
11	a	a	DT	DT	_	15	det	_	_
12	possible	possible	JJ	JJ	_	15	amod	_	_
13	live	live	JJ	JJ	_	15	amod	_	_
14	nasal	nasal	JJ	JJ	_	15	amod	_	_
15	vaccine	vaccine	NN	NN	_	10	pobj	_	_
16	for	for	IN	IN	_	15	prep	_	_
17	the	the	DT	DT	_	18	det	_	_
18	prevention	prevention	NN	NN	_	16	pobj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	whooping	whooping	JJ	JJ	_	21	amod	_	_
21	cough	cough	NN	NN	_	19	pobj	_	_
22	.	.	.	.	_	9	punct	_	_

1	It	it	PRP	PRP	_	3	nsubj	_	_
2	is	be	VBZ	VBZ	_	3	cop	_	_
3	immunogenic	immunogenic	JJ	JJ	_	0	ROOT	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	safe	safe	JJ	JJ	_	3	conj	_	_
6	when	when	WRB	WRB	_	7	advmod	_	_
7	given	give	VBN	VBN	_	3	advcl	_	_
8	intranasally	intranasally	RB	RB	_	7	advmod	_	_
9	in	in	IN	IN	_	8	prep	_	_
10	adult	adult	JJ	JJ	_	11	amod	_	_
11	volunteers	volunteer	NNS	NNS	_	9	pobj	_	_
12	.	.	.	.	_	3	punct	_	_

1	Before	before	IN	IN	_	8	prep	_	_
2	testing	testing	NN	NN	_	1	pobj	_	_
3	in	in	IN	IN	_	2	prep	_	_
4	human	human	JJ	JJ	_	5	amod	_	_
5	infants	infant	NNS	NNS	_	3	pobj	_	_
6	,	,	,	,	_	8	punct	_	_
7	we	we	PRP	PRP	_	8	nsubj	_	_
8	wished	wish	VBD	VBD	_	0	ROOT	_	_
9	to	to	TO	TO	_	10	aux	_	_
10	examine	examine	VB	VB	_	8	xcomp	_	_
11	the	the	DT	DT	_	13	det	_	_
12	potential	potential	JJ	JJ	_	13	amod	_	_
13	effect	effect	NN	NN	_	10	dobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	BPZE1	bpze1	NN	NN	_	14	pobj	_	_
16	on	on	IN	IN	_	13	prep	_	_
17	a	a	DT	DT	_	20	det	_	_
18	common	common	JJ	JJ	_	20	amod	_	_
19	pediatric	pediatric	JJ	JJ	_	20	amod	_	_
20	infection	infection	NN	NN	_	16	pobj	_	_
21	-LRB-	-lrb-	-LRB-	-LRB-	_	24	punct	_	_
22	respiratory	respiratory	JJ	JJ	_	24	amod	_	_
23	syncytial	syncytial	JJ	JJ	_	24	amod	_	_
24	virus	virus	NN	NN	_	20	dep	_	_
25	-LSB-	-lsb-	-LRB-	-LRB-	_	26	punct	_	_
26	RSV	rsv	NN	NN	_	24	appos	_	_
27	-RSB-	-rsb-	-RRB-	-RRB-	_	26	punct	_	_
28	-RRB-	-rrb-	-RRB-	-RRB-	_	24	punct	_	_
29	in	in	IN	IN	_	10	prep	_	_
30	a	a	DT	DT	_	32	det	_	_
31	preclinical	preclinical	JJ	JJ	_	32	amod	_	_
32	model	model	NN	NN	_	29	pobj	_	_
33	.	.	.	.	_	8	punct	_	_

1	BPZE1	bpze1	NN	NN	_	3	nsubjpass	_	_
2	was	be	VBD	VBD	_	3	auxpass	_	_
3	administered	administer	VBN	VBN	_	0	ROOT	_	_
4	before	before	IN	IN	_	3	prep	_	_
5	or	or	CC	CC	_	4	cc	_	_
6	after	after	IN	IN	_	4	conj	_	_
7	RSV	RSV	NNP	NNP	_	8	nn	_	_
8	administration	administration	NN	NN	_	4	pobj	_	_
9	in	in	IN	IN	_	8	prep	_	_
10	adult	adult	JJ	JJ	_	13	amod	_	_
11	or	or	CC	CC	_	10	cc	_	_
12	neonatal	neonatal	JJ	JJ	_	10	conj	_	_
13	mice	mouse	NNS	NNS	_	9	pobj	_	_
14	.	.	.	.	_	3	punct	_	_

1	Pathogen	pathogen	NN	NN	_	2	nn	_	_
2	replication	replication	NN	NN	_	14	nsubjpass	_	_
3	,	,	,	,	_	2	punct	_	_
4	inflammation	inflammation	NN	NN	_	2	conj	_	_
5	,	,	,	,	_	2	punct	_	_
6	immune	immune	JJ	JJ	_	8	amod	_	_
7	cell	cell	NN	NN	_	8	nn	_	_
8	recruitment	recruitment	NN	NN	_	2	conj	_	_
9	,	,	,	,	_	2	punct	_	_
10	and	and	CC	CC	_	2	cc	_	_
11	cytokine	cytokine	NN	NN	_	12	nn	_	_
12	responses	response	NNS	NNS	_	2	conj	_	_
13	were	be	VBD	VBD	_	14	auxpass	_	_
14	measured	measure	VBN	VBN	_	0	ROOT	_	_
15	.	.	.	.	_	14	punct	_	_

1	BPZE1	bpze1	NN	NN	_	5	nsubj	_	_
2	alone	alone	RB	RB	_	1	advmod	_	_
3	did	do	VBD	VBD	_	5	aux	_	_
4	not	not	RB	RB	_	5	neg	_	_
5	cause	cause	VB	VB	_	0	ROOT	_	_
6	overt	overt	JJ	JJ	_	7	amod	_	_
7	disease	disease	NN	NN	_	5	dobj	_	_
8	,	,	,	,	_	5	punct	_	_
9	but	but	CC	CC	_	5	cc	_	_
10	induced	induce	VBD	VBD	_	5	conj	_	_
11	efflux	efflux	NN	NN	_	10	dobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	neutrophils	neutrophil	NNS	NNS	_	12	pobj	_	_
14	into	into	IN	IN	_	10	prep	_	_
15	the	the	DT	DT	_	17	det	_	_
16	airway	airway	NN	NN	_	17	nn	_	_
17	lumen	lumen	NN	NN	_	14	pobj	_	_
18	and	and	CC	CC	_	10	cc	_	_
19	production	production	NN	NN	_	10	conj	_	_
20	of	of	IN	IN	_	19	prep	_	_
21	IL-10	il-10	NN	NN	_	20	pobj	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	IL-17	il-17	NN	NN	_	21	conj	_	_
24	by	by	IN	IN	_	19	prep	_	_
25	mucosal	mucosal	JJ	JJ	_	26	amod	_	_
26	CD4	cd4	NN	NN	_	24	pobj	_	_
27	-LRB-	-lrb-	-LRB-	-LRB-	_	28	punct	_	_
28	+	+	CC	CC	_	26	dep	_	_
29	-RRB-	-rrb-	-RRB-	-RRB-	_	28	punct	_	_
30	T	t	NN	NN	_	31	nn	_	_
31	cells	cell	NNS	NNS	_	26	dep	_	_
32	.	.	.	.	_	5	punct	_	_

1	Given	give	VBN	VBN	_	9	vmod	_	_
2	intranasally	intranasally	RB	RB	_	1	advmod	_	_
3	before	before	IN	IN	_	1	prep	_	_
4	RSV	rsv	NN	NN	_	5	nn	_	_
5	infection	infection	NN	NN	_	3	pobj	_	_
6	,	,	,	,	_	9	punct	_	_
7	BPZE1	bpze1	NN	NN	_	9	nsubj	_	_
8	markedly	markedly	RB	RB	_	9	advmod	_	_
9	attenuated	attenuate	VBD	VBD	_	0	ROOT	_	_
10	RSV	RSV	NNP	NNP	_	9	dobj	_	_
11	,	,	,	,	_	9	punct	_	_
12	preventing	prevent	VBG	VBG	_	9	dep	_	_
13	weight	weight	NN	NN	_	14	nn	_	_
14	loss	loss	NN	NN	_	12	dobj	_	_
15	,	,	,	,	_	12	punct	_	_
16	reducing	reduce	VBG	VBG	_	12	vmod	_	_
17	viral	viral	JJ	JJ	_	18	amod	_	_
18	load	load	NN	NN	_	16	dobj	_	_
19	,	,	,	,	_	12	punct	_	_
20	and	and	CC	CC	_	12	cc	_	_
21	attenuating	attenuate	VBG	VBG	_	24	amod	_	_
22	lung	lung	NN	NN	_	24	nn	_	_
23	cell	cell	NN	NN	_	24	nn	_	_
24	recruitment	recruitment	NN	NN	_	12	conj	_	_
25	.	.	.	.	_	9	punct	_	_

1	Given	give	VBN	VBN	_	6	vmod	_	_
2	neonatally	neonatally	RB	RB	_	1	advmod	_	_
3	,	,	,	,	_	6	punct	_	_
4	BPZE1	bpze1	NN	NN	_	6	nsubj	_	_
5	also	also	RB	RB	_	6	advmod	_	_
6	protected	protect	VBD	VBD	_	0	ROOT	_	_
7	against	against	IN	IN	_	6	prep	_	_
8	RSV-induced	rsv-induced	JJ	JJ	_	10	amod	_	_
9	weight	weight	NN	NN	_	10	nn	_	_
10	loss	loss	NN	NN	_	7	pobj	_	_
11	even	even	RB	RB	_	12	advmod	_	_
12	through	through	IN	IN	_	6	prep	_	_
13	to	to	TO	TO	_	12	pcomp	_	_
14	adulthood	adulthood	NN	NN	_	13	pobj	_	_
15	.	.	.	.	_	6	punct	_	_

1	Furthermore	furthermore	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	it	it	PRP	PRP	_	5	nsubj	_	_
4	markedly	markedly	RB	RB	_	5	advmod	_	_
5	increased	increase	VBD	VBD	_	0	ROOT	_	_
6	IL-17	il-17	NN	NN	_	7	nn	_	_
7	production	production	NN	NN	_	5	dobj	_	_
8	by	by	IN	IN	_	5	prep	_	_
9	CD4	cd4	NN	NN	_	8	pobj	_	_
10	-LRB-	-lrb-	-LRB-	-LRB-	_	11	punct	_	_
11	+	+	CC	CC	_	9	dep	_	_
12	-RRB-	-rrb-	-RRB-	-RRB-	_	11	punct	_	_
13	T	t	NN	NN	_	14	nn	_	_
14	cells	cell	NNS	NNS	_	9	conj	_	_
15	and	and	CC	CC	_	9	cc	_	_
16	natural	natural	JJ	JJ	_	18	amod	_	_
17	killer	killer	NN	NN	_	18	nn	_	_
18	cells	cell	NNS	NNS	_	9	conj	_	_
19	and	and	CC	CC	_	5	cc	_	_
20	recruited	recruit	VBN	VBN	_	22	amod	_	_
21	regulatory	regulatory	JJ	JJ	_	22	amod	_	_
22	cells	cell	NNS	NNS	_	5	conj	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	neutrophils	neutrophil	NNS	NNS	_	22	conj	_	_
25	after	after	IN	IN	_	22	prep	_	_
26	virus	virus	NN	NN	_	27	nn	_	_
27	challenge	challenge	NN	NN	_	25	pobj	_	_
28	.	.	.	.	_	5	punct	_	_

1	Administration	administration	NN	NN	_	5	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	anti-IL-17	anti-il-17	JJ	JJ	_	4	amod	_	_
4	antibodies	antibody	NNS	NNS	_	2	pobj	_	_
5	ablated	ablate	VBD	VBD	_	0	ROOT	_	_
6	the	the	DT	DT	_	8	det	_	_
7	protective	protective	JJ	JJ	_	8	amod	_	_
8	effect	effect	NN	NN	_	5	dobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	BPZE1	bpze1	NN	NN	_	9	pobj	_	_
11	on	on	IN	IN	_	8	prep	_	_
12	RSV	rsv	NN	NN	_	13	nn	_	_
13	disease	disease	NN	NN	_	11	pobj	_	_
14	.	.	.	.	_	5	punct	_	_

1	Rather	rather	RB	RB	_	2	advmod	_	_
2	than	than	IN	IN	_	8	prep	_	_
3	enhancing	enhance	VBG	VBG	_	2	pcomp	_	_
4	RSV	rsv	NN	NN	_	5	nn	_	_
5	disease	disease	NN	NN	_	3	dobj	_	_
6	,	,	,	,	_	8	punct	_	_
7	BPZE1	bpze1	NN	NN	_	8	nsubj	_	_
8	protected	protect	VBD	VBD	_	0	ROOT	_	_
9	against	against	IN	IN	_	8	prep	_	_
10	viral	viral	JJ	JJ	_	11	amod	_	_
11	infection	infection	NN	NN	_	9	pobj	_	_
12	,	,	,	,	_	8	punct	_	_
13	modified	modify	VBN	VBN	_	15	amod	_	_
14	viral	viral	JJ	JJ	_	15	amod	_	_
15	responses	response	NNS	NNS	_	8	dobj	_	_
16	,	,	,	,	_	8	punct	_	_
17	and	and	CC	CC	_	8	cc	_	_
18	enhanced	enhance	VBD	VBD	_	8	conj	_	_
19	natural	natural	JJ	JJ	_	21	amod	_	_
20	mucosal	mucosal	JJ	JJ	_	21	amod	_	_
21	resistance	resistance	NN	NN	_	18	dobj	_	_
22	.	.	.	.	_	8	punct	_	_

1	Prevention	Prevention	NNP	NNP	_	7	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	RSV	rsv	NN	NN	_	4	nn	_	_
4	infection	infection	NN	NN	_	2	pobj	_	_
5	by	by	IN	IN	_	1	prep	_	_
6	BPZE1	bpze1	NN	NN	_	5	pobj	_	_
7	seems	seem	VBZ	VBZ	_	0	ROOT	_	_
8	in	in	IN	IN	_	7	prep	_	_
9	part	part	NN	NN	_	8	pobj	_	_
10	to	to	TO	TO	_	12	aux	_	_
11	be	be	VB	VB	_	12	auxpass	_	_
12	caused	cause	VBN	VBN	_	7	xcomp	_	_
13	by	by	IN	IN	_	12	prep	_	_
14	induction	induction	NN	NN	_	13	pobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	IL-17	il-17	NN	NN	_	15	pobj	_	_
17	.	.	.	.	_	7	punct	_	_

1	Clinical	clinical	JJ	JJ	_	2	amod	_	_
2	trial	trial	NN	NN	_	0	ROOT	_	_
3	registered	register	VBN	VBN	_	2	vmod	_	_
4	with	with	IN	IN	_	3	prep	_	_
5	www.clinicaltrials.gov	www.clinicaltrials.gov	NN	NN	_	4	pobj	_	_
6	-LRB-	-lrb-	-LRB-	-LRB-	_	7	punct	_	_
7	NCT	nct	NN	NN	_	5	appos	_	_
8	01188512	01188512	CD	CD	_	7	num	_	_
9	-RRB-	-rrb-	-RRB-	-RRB-	_	7	punct	_	_
10	.	.	.	.	_	2	punct	_	_
